Get the Stockscreener App
1.82
2.15%
-0.04
After Hours:
1.83
0.01
+0.55%
Waldencast Plc stock is traded at $1.82, with a volume of 802.83K.
It is down -2.15% in the last 24 hours and up +23.81% over the past month.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
See More
Previous Close:
$1.86
Open:
$1.88
24h Volume:
802.83K
Relative Volume:
0.71
Market Cap:
$233.43M
Revenue:
$272.07M
Net Income/Loss:
$-248.06M
P/E Ratio:
-0.9025
EPS:
-2.0167
Net Cash Flow:
$-16.48M
1W Performance:
+10.98%
1M Performance:
+23.81%
6M Performance:
-4.21%
1Y Performance:
-17.27%
1-Day Range:
$1.665
$1.90
1-Week Range:
$1.63
$1.925
52-Week Range:
$0.72
$3.22
Waldencast Plc Stock (WALD) Company Profile
Name
Waldencast Plc
Sector
Industry
Phone
(917) 546-6828
Address
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.82 | 238.56M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
150.46 | 348.38B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.69 | 127.59B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.58 | 71.58B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
18.25 | 34.83B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
103.14 | 33.95B | 16.56B | 1.75B | 1.84B | 6.36 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-26 | Resumed | Jefferies | Buy |
| Nov-25-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Apr-22-25 | Initiated | Alliance Global Partners | Buy |
| Dec-16-24 | Initiated | TD Cowen | Hold |
| Oct-25-24 | Initiated | Canaccord Genuity | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Waldencast Plc Stock (WALD) Latest News
FDA approves Obagi saypha ChIQ filler from Waldencast (NASDAQ: WALD) - Stock Titan
Waldencast receives FDA approval for Obagi saypha ChIQ filler By Investing.com - Investing.com India
Waldencast receives FDA approval for Obagi saypha ChIQ filler - Investing.com
FDA approves Obagi cheek-augmentation filler for midface contour issues - Stock Titan
Waldencast Q4 2024 Earnings: EPS Misses Estimates Amidst Challenging QuarterPost-Earnings Drift - newsline.com
WALD Q4 2024 Earnings: Significant EPS Miss Raises Concerns Amidst Growth StrategyDividend Growth Analysis - newsline.com
Waldencast plc (WALD) Q4 2024 Earnings: Significant EPS Miss Highlights Profitability PressuresShare Dilution Risk - newsline.com
Watkins Advises Bridgepoint in Acquisition of Obagi Medical From Waldencast - Latham & Watkins LLP
Canaccord raises Waldencast stock price target on Obagi sale By Investing.com - Investing.com Australia
Canaccord raises Waldencast stock price target on Obagi sale - Investing.com
WALD ALERT: Hagens Berman, National Trial Attorneys, Encourages Waldencast plc (WALD) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations - TMX Newsfile
Waldencast (WALD) Gains 3.28%: Testing Key Resistance Levels After Recent VolatilitySentiment Shift - newsline.com
Obagi Medical sold to Bridgepoint as Waldencast focuses on Milk Makeup brand - FashionNetwork USA
Waldencast Announces Sale of Obagi Medical To Bridgepoint - Happi | Household And Personal Products Industry
Waldencast agrees to sell Obagi Medical for up to $460 million By Investing.com - Investing.com India
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup - TipRanks
Waldencast plc Announces CEO Changes - marketscreener.com
Obagi sale lets Waldencast (NASDAQ: WALD) cut debt and focus Milk - Stock Titan
Waldencast Announces Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast agrees to sell Obagi Medical for up to $460 million - Investing.com
Sale of Obagi for up to $460M lets Waldencast refocus on Milk Makeup - Stock Titan
Waldencast plc Warrant (WALDW) Surges 21.7%: Micro-Cap Warrant Sees Renewed InterestBear Pennant - newsline.com
WALD Q4 2024 Earnings: EPS Misses Estimates as Losses WidenRevenue Warning Signal - newsline.com
Waldencast's (WALD) CFO/COO Gautier Abruptly Exits Amid SEC's Investigation into Company's Improper AccountingHagens Berman - TMX Newsfile
Waldencast Warrants (WALDW) Edge Higher at $0.04 Amid Tight Trading RangeBullish Percent Index - The Legal Advocate
Waldencast (WALD) Q4 2024 Earnings: Significant EPS Miss Reflects Persistent Operational ChallengesRevenue Surprise History - Newser
Why Waldencast (WALDW) Just Dropped -14.89% — What to Watch 2026-05-20TRIN Signal - newsline.com
Waldencast plcClass A Ordinary Share (NQ: WALD - The Chronicle-Journal
Obagi Medical Shares New Data on Recent Innovations at - GlobeNewswire
Obagi study: 94% of injectors back new filler, serum tied to younger skin - Stock Titan
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience - GlobeNewswire
TradingKey - TradingKey
How Waldencast (WALD) Story Is Shifting As Targets Fall And Brand Hopes Persist - Yahoo Finance
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* - GlobeNewswire
Waldencast Stock Steadies As SEC Closes Probe On Obagi Accounting - timothysykes.com
Waldencast announces conclusion of SEC investigation - The Manila Times
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues - TipRanks
SEC closes Waldencast accounting probe, no enforcement planned - Stock Titan
Waldencast plc Exonerated by SEC Following Investigation into Financial Reporting Practices - Quiver Quantitative
SEC ends Waldencast (NASDAQ: WALD) investigation with no enforcement action - Stock Titan
SEC Drops Investigation Into Waldencast - marketscreener.com
WALD - Finviz
WALD Should I Buy - Intellectia AI
Waldencast (WALDW) Stock: Market Catalysts Overview (Smart Money Exits) 2026-04-22Shared Buy Zones - Xã Thanh Hà
Kelly Brookie Net Worth (2026) - GuruFocus
Waldencast (WALD) Stock Trending Today (Trend Weakens) 2026-04-18Verified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Manuel Manfredi Net Worth (2026) - GuruFocus
Waldencast Acquisition Corp (WALDW) - Minichart
Waldencast PLC (NASDAQ:WALD) Short Interest Down 19.3% in March - MarketBeat
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Waldencast Plc Stock (WALD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.32%
4.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):